- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Genetic Technologies Ltd
+ Add to WatchlistGENE:US
3.1000 USD 0.0100 0.32%As of 20:10:00 ET on 05/24/2013.
Snapshot for Genetic Technologies Ltd (GENE)
| Open: | 3.0400 | Day's Range: | 2.9200 - 3.1100 | Volume: | 84,047 |
|---|---|---|---|---|---|
| Previous Close: | 3.1000 | 52wk Range: | 2.0000 - 6.1900 | 1-Yr Rtn: | -35.68% |
Key Statistics for GENE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (AUD) (ttm) | - |
| Est. EPS (AUD) (06/2013) | -0.4720 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 49.13 |
| Shares Outstanding (M) | 15.85 |
| 30 Day Average Volume | 201,327 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GENE
Company Profile & Key Executives for GENE
Genetic Technologies Limited is a biotechnology company which does advanced DNA genetic research and testing. The Company has several gene-based patents which include intron sequence analysis, genomic mapping and fetal cell recovery. Genetic also operates a testing laboratory that performs disputed paternity testing by DNA techniques.
| Malcolm R Brandon "Mal"Chairman | Alison J MewChief Executive Officer |
| Thomas Godfrey Howitt "Tom"CFO/Secretary | Mark OstrowskiSenior VP:Sales & Marketing |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GENE News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page